Canada markets close in 2 hours 54 minutes

Auxly Cannabis Group Inc. (XLY.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.13000.0000 (0.00%)
As of 12:53PM EDT. Market open.
Full screen
Previous Close0.1300
Open0.1350
Bid0.1300 x 0
Ask0.1350 x 0
Day's Range0.1300 - 0.1400
52 Week Range0.1300 - 0.9000
Volume460,082
Avg. Volume838,925
Market Cap82.153M
Beta (5Y Monthly)3.56
PE Ratio (TTM)N/A
EPS (TTM)-0.1880
Earnings DateNov. 19, 2020 - Nov. 23, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.36
  • GlobeNewswire

    Auxly’s Subsidiary KGK Science Receives Research Licence to Conduct Product Palatability and Sensory Testing with Human Subjects

    TORONTO, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the “Company”), a consumer packaged goods company in the cannabis products market, is thrilled to announce that its wholly owned subsidiary, KGK Science Inc. (“KGK”) has received its second Cannabis Research Licence from Health Canada pursuant to the Cannabis Act. This licence permits KGK to administer cannabis extracts, edible cannabis and cannabis topicals to human subjects for purposes of palatability and sensory testing at its clinical research facility located in London, Ontario. Sensory evaluation measures, analyzes and interprets the reaction of human subjects to products as perceived by the senses, it is an incredibly valuable tool in understanding and determining consumer preferences and the basis for those differences. As the cannabis industry continues to expand and new products are being introduced to the market, KGK will be able use their existing database of over 25,000 participants to provide palatability and sensory studies to all licenced producers across Canada that are seeking to undertake controlled focus groups on any cannabis product development initiatives.Hugo Alves, CEO of Auxly stated: “This exciting and strategic milestone further expands and establishes KGK’s presence and leadership role in the cannabis industry. Their remarkable science team and commitment to ensuring safe and effective cannabis products for Canadian consumers is what continues to set them apart. We couldn’t be more proud of the KGK team!”“Securing this license is another step towards maintaining our commitment to provide leading research to support growth in the cannabis industry,” says KGK President and CEO Najla Guthrie. “Facilitating the evaluation of cannabis products aligns with our decades of experience implementing cutting-edge clinical science to help companies bring safe and effective natural health products to market. We look forward to contributing to the success of innovative, consumer-tested cannabis products for the Canadian cannabis industry.”ON BEHALF OF THE BOARD "Hugo Alves" CEO About Auxly Cannabis Group Inc. (TSX.V: XLY) Auxly is an international cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the medical, wellness and adult-use markets. Auxly's experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.About KGK Science Inc. KGK Science, a wholly owned subsidiary of Auxly, is a premium contract research organization (CRO) offering high-quality clinical research trials and expert regulatory support for the nutraceutical, cannabis and hemp industries. For over 22 years, KGK has successfully helped hundreds of companies with custom designed clinical trials and claim substantiation strategies that move products efficiently into global markets. Equipped with state-of-the-art technologies, novel research techniques, and a seasoned team of industry experts, KGK Science remains at the forefront of its industry, consolidating scientific, clinical, commercial, and regulatory expertise with innovation and agility to serve the expanding needs of global business and consumers. Visit us at www.kgkscience.comLearn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.Investor Relations: For investor enquiries please contact our Investor Relations Team:  Email: IR@auxly.com Phone: 1.833.695.2414Media Enquiries (only):  For media enquiries or to set up an interview please contact: Email: press@auxly.com Notice Regarding Forward Looking Information: This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: the Company’s execution of its product development and commercialization strategy; the anticipated benefits of KGK’s research and development initiatives; consumer preferences; political change, future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting the Company in particular and the cannabis industry generally.A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to, whether: KGK is able to maintain the Cannabis Research Licence and its other current licences, and obtain and maintain all other necessary governmental and regulatory authorizations and permits to conduct business; the success of KGK’s research strategies and the applicability of the discoveries made therein; and general economic, financial market, regulatory and political conditions in which the Company operates will remain the same. Additional risk factors are disclosed in the annual information form of the Company for the financial year ended December 31, 2019 dated May 13, 2020.New factors emerge from time to time, and it is not possible for management to predict all of those factors or to assess in advance the impact of each such factor on Auxly’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. In addition, this release may contain forward-looking information attributed to third party industry sources, the accuracy of which has not been verified by Auxly. The purpose of forward-looking information is to provide the reader with a description of management's expectations, and such forward-looking information may not be appropriate for any other purpose. Readers should not place undue reliance on forward-looking information contained in this release. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, Auxly does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

  • Move Over Pumpkin Spice: Foray Rings in Fall with Cannabis-Infused Hard Maple Caramels
    GlobeNewswire

    Move Over Pumpkin Spice: Foray Rings in Fall with Cannabis-Infused Hard Maple Caramels

    Foray Hard Maple Caramels Foray Hard Maple Caramels Foray Hard Maple Caramels Packaging Foray Hard Maple Caramels Packaging Foray Hard Maple Caramels arrive in cannabis retail stores this October As pumpkin-spice-everything season begins, a national consumer survey finds that Canadians actually prefer mapleTORONTO, Sept. 22, 2020 (GLOBE NEWSWIRE) -- It’s official – the tyranny of pumpkin spice is over. The latest autumnal flavour for Canadian cannabis consumers is a new twist on a familiar classic – cannabis-infused Hard Maple Caramels from Foray. Made using real Canadian maple syrup, butter, cream – and of course, cannabis – Foray Hard Maple Caramels are coming to cannabis retail stores across Canada this October. This launch offers a welcome respite from the onslaught of all-things pumpkin spice in the fall season, as evidenced by a national consumer survey commissioned by Foray1, which found that 74%, or nearly three quarters, of Canadians prefer the flavour of maple to pumpkin spice. Foray is a cannabis brand owned and operated by Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly”).Foray Hard Maple Caramels represent a new product category for cannabis 2.0 consumers, developed by Auxly’s product innovation team. Hard Maple Caramels will be available in a two pack, with each piece containing 5 mg of THC. Each piece is made using real maple syrup, sourced from a co-operative in New Brunswick, along with real butter and cream, and a Sativa/Indica cannabis blend. Foray Hard Maple Caramels are manufactured in Charlottetown, Prince Edward Island, where each batch undergoes rigorous testing to ensure a high-quality, consistent dosage with every use.“At Foray, we’re constantly researching about new products to bring to the marketplace for both novice and more experienced consumers, and we’re thrilled to launch Foray Hard Maple Caramels in time for the fall season,” said Eric Goulet, Brand Director, Foray. “Congratulations to the entire product innovation team for bringing an exciting new product category to the Canadian market with Foray Hard Maple Caramels.”Image: Foray Hard Maple Caramels. https://www.globenewswire.com/NewsRoom/AttachmentNg/6e899b17-4dc6-4076-aa04-1fee28b81ff1Image: Foray Hard Maple Caramels packaging. https://www.globenewswire.com/NewsRoom/AttachmentNg/5ea63ec8-01a5-439c-939c-9e8ee6168537Knowing that the fall season typically triggers an avalanche of consumer products flavoured with pumpkin spice, Foray commissioned a survey asking Canadians which flavour they prefer – maple or pumpkin spice. The results were overwhelmingly in favour of maple. Nationally, 74% of Canadians prefer maple to pumpkin spice. Regionally, Quebec (88%), Ontario (73%) and Alberta (72%) showed the highest preference for maple, with Manitoba (64%) and Saskatchewan (59%) demonstrating the lowest preference. Demographically, 83% of men and 67% of women prefer maple; interestingly, women (33%) were nearly twice as likely as men (17%) to prefer pumpkin spice.Hard Maple Caramels join Foray’s line-up of popular Cannabis 2.0 products, which includes: Soft Chews, in Raspberry Vanilla (THC) and Peach Mango (Balanced) formulations; Chocolate, in Dark Chocolate (THC), Vanilla Chai Milk Chocolate (THC), and Salted Caramel (Balanced) varieties; and Vapes, in strains such as Blackberry Cream (Indica), Strawberry Ice (Sativa), Maui Wowie (Sativa), Mango Haze (Balanced and CBD), and Goji OG (Hybrid).About Foray Foray is an accessible cannabis brand designed for curious consumers at any stage of their cannabis journey, wholly owned by Auxly Cannabis Group Inc. High-quality Foray cannabis products, available at licensed cannabis retailers across Canada, include premium vapes, soft chews, chocolates and hard maple caramels. See cannabis differently. Learn more at myforay.com and stay up-to-date at Twitter: @foraycannabis; Instagram: @forayofficial; Facebook: @foraycannabis.About Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) Auxly is an international cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the medical, wellness and adult-use markets. Auxly's experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.For more information on the consumer survey, and for interviews requests for Eric Goulet, please contact: Scott Campbell, 647-402-4957, press@auxly.com Notice Regarding Forward Looking Information:This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: consumer preferences, political change, future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting Auxly in particular and the cannabis industry generally.A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to whether: there is acceptance and demand for Foray products by consumers and provincial purchasers; and general economic, financial market, regulatory and political conditions in which Auxly operates will remain the same. The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. Readers should not place undue reliance on forward-looking information contained in this release. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.1 Maru/Blue survey of 1,511 randomly selected Canadian adults, conducted on September 16 and 17, 2020. For comparison purposes, a probability sample of this size has an estimated margin of error (which measures sampling variability) of +/- 2.5%, 19 times out of 20. The results have been weighted by education, age, gender and region (and in Quebec, language) to match the population, according to Census data. This is to ensure the sample is representative of the entire adult population of Canada. Discrepancies in or between totals are due to rounding.

  • GlobeNewswire

    Auxly Files Early Warning Report

    TORONTO, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") announces pursuant to the requirements of National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting Issues and applicable Canadian securities legislation that on September 17, 2020, the Company completed a disposition of 6,000,000 common shares and $400,000 worth of convertible debentures of Inner Spirit Holdings Ltd. (“Inner Spirit”) for gross proceeds of $845,400, which reduces Auxly’s security holding percentage in Inner Spirit from 12.9% to 9.8%. The disposition was completed through the Canadian Securities Exchange where Inner Spirit's common shares and convertible debentures are listed for trading. Since Auxly’s security holding percentage of Inner Spirit is now below 10%, following the filing of the early warning report in connection with the disposition, Auxly will no longer file early warning or insider reports in respect of Auxly’s ownership of Inner Spirit’s securities, except as may be required by applicable law. Following the disposition, Auxly continues to have ownership and control of 19,941,177 common shares, 3,000,000 warrants, and 600,000 options to purchase common shares of Inner Spirit. The disposition of the Inner Spirit securities was undertaken by Auxly as part of its strategy to monetize non-core assets to fund capital and operational expenditures for its core assets. While Auxly has no current plans or intentions relating to Inner Spirit securities, depending on various factors including, without limitation, Inner Spirit's financial position, the price levels of the common shares of Inner Spirit, conditions in the securities markets, general economic and industry conditions, Inner Spirit's business or financial condition, and other factors and conditions deemed appropriate, Auxly may acquire or dispose of additional securities of Inner Spirit in the future but has no current plans or future intentions to do so.“We remain incredibly supportive of Inner Spirit and are committed to our continued relationship as they lead the market in opening retail cannabis stores across the country,” said Hugo Alves, CEO of Auxly.An early warning report pursuant to the requirements of applicable securities laws has been filed by Auxly and is posted to Inner Spirit's SEDAR profile at www.sedar.com, and is available on request at the number and email address below. Inner Spirit's head office is located at 102, 5740 2nd Street SW, Calgary, Alberta, T2H 1Y6 and Auxly's head office address is located at 777 Richmond St. W Unit 002 Toronto, ON, M6J 0C2.ON BEHALF OF THE BOARD "Hugo Alves" CEOAbout Auxly Cannabis Group Inc. (TSX.V: XLY)Auxly is an international cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the medical, wellness and adult-use markets. Auxly's experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.Investor Relations:For investor enquiries please contact our Investor Relations Team: Email: IR@auxly.com Phone: 1.833.695.2414Media Enquiries (only):For media enquiries or to set up an interview please contact: Email: press@auxly.comNeither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.